Key result
Commentary reviews sequential nephron versus renin-angiotensin system blockade for resistant hypertension without new clinical data.
Commentary on blockade strategies in resistant hypertension adds no new data; leaves comparative efficacy open for prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shaik et al. (2026) studied this question. Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension is discussed in this commentary, which presents no new clinical data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: